arrow
C

Christian F. Clarenbach

University of Zurich
H指数:34
被引数:3,867

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment patterns, disease progression and survival in Sjogren disease-associated interstitial lung disease: a multicentre European cohort study

Sjogren综合征相关间质性肺疾病的治疗模式、疾病进展和生存情况:一项多中心欧洲队列研究

2026-08-010
OAAI
Dissociation of the Hepatic and Pulmonary Axes in Alpha-1 Antitrypsin Deficiency: Independent Trajectories of Organ-Specific Disease

α-1抗胰蛋白酶缺乏症中肝肺轴的分离:器官特异性疾病的独立轨迹

2026-07-280
OA
Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis

III类MAP2K1突变与多系统朗格汉斯细胞组织细胞增多症的频繁复发和多线治疗相关

2026-06-170
OAAI
Characteristics of bronchiectasis in patients with different genotypes of severe α1-antitrypsin deficiency from the EARCO registry

不同基因型严重α1-抗胰蛋白酶缺乏症患者支气管扩张的特征:来自EARCO注册研究

2026-02-090
PRE
Routine blood biomarkers in patients with the PI*SZ genotype of alpha-1 antitrypsin deficiency: Data from the EARCO Registry

α1-抗胰蛋白酶缺陷症PI*SZ基因型患者的常规血液生物标志物:EARCO登记研究的数据

2026-01-090
PRE
The Effect of Comorbidities on Asthma-Related Outcomes Over a Two-Year Period: A Prospective Analysis of Swiss Severe Asthma Registry (SSAR)

共病对哮喘相关结局两年期的影响:一项瑞士重症哮喘登记研究(SSAR)的前瞻性分析

2025-07-150
OAAI
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study

预测系统性硬化相关性间质性肺疾病进展患者后续进展风险:一项多中心观察性队列研究

2025-05-140
PRE
Characterization of the Mmalton carrier's cohort within the EARCO (European Alpha-1 Antitrypsin Research Collaboration) registry

EARCO(欧洲α1抗胰蛋白酶研究合作)登记库中Mmalton携带者队列的特征分析

2025-04-230
OA
Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans

通过标准剂量和低剂量HRCT扫描验证一种半定量方法,用于评估系统性硬化症中肺间质疾病的严重程度和进展。

2025-02-270
OA
Prediction of stable SSc-ILD depends on definition of ILD progression
2024-10-300
PRE
Gender-specific aspects of alpha-1-antitrypsin deficiency in relation to lung and liver disease, symptom burden and exacerbations: Data from the EARCO registry
2024-10-300
PRE